IP Library Granted Patent US 10,041,946
Granted Patent B2
US 10,041,946 · App. 15/879,547 · Granted Aug 7, 2018

Reagents for HCV antigen-antibody combination assays

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,041,946
App. No.
15/879,547
Granted
Aug 7, 2018
Kind
B2
Abstract

The present invention is directed to combination immunoassays, reagents and kits for simultaneous detection of HCV antigens and anti-HCV antibodies in a sample. The combination immunoassays of the present invention employ a non-ionic detergent that effectively exposes or releases the HCV core antigen from virions in a sample without interfering with the performance of other reagents such as the capture of anti-HCV antibodies by recombinant HCV antigens.

Claims (12)

1. A kit for simultaneously detecting HCV antigens and antibodies in a sample, comprising a non-ionic detergent comprising an N-alkyl-N,N-dimethyl-amine oxide, a first pair of a capture antigen and a detection antigen, a first pair of a capture antibody and a conjugate antibody, wherein said capture antigen and said detection antigen comprise a first peptide fragment of a first HCV protein, said capture antibody and said conjugate antibody specifically bind to a second HCV protein, and said detection antigen and said conjugate antibody comprise one and same signal generating means.

2. The kit of claim 1 , wherein said N-alkyl-N,N-dimethyl-amine oxide is characterized by the formula, CH3-(CH2)n-N + —(CH3)20 − , wherein n falls in the range of 9 to 13.

3. The kit of claim 2 , wherein said N-alkyl-N,N-dimethyl-amine oxide is Lauryldimethylamine N-oxide (LDAO).

4. The kit of claim 1 , wherein said first HCV protein and said second HCV protein are independently selected from the group consisting of the core antigen, E 1, E2, NS2, NS3, NS4, and NS5.

5. The kit of claim 1 , wherein said first HCV protein and said second HCV protein are the same, and said capture antibody and said conjugate antibody bind to a region of said second HCV protein outside of said first peptide fragment.

6. The kit of claim 5 , wherein said first HCV protein and said second HCV protein are both the HCV core antigen.

7. The kit of claim 1 , further comprising a second pair of a capture antigen and a detection antigen is provided, wherein said capture antigen and said detection antigen of the second pair comprise a second peptide fragment of an HCV protein, wherein said second peptide fragment is different from said first peptide fragment.

8. The kit of claim 7 , wherein said first peptide fragment and said second peptide fragment are derived from different HCV proteins.

9. The kit of claim 8 , wherein at least one of said first peptide fragment or said second peptide fragment is a fragment of the HCV core antigen.

10. The kit of claim 1 , wherein said capture antibody in said first pair comprises two or more antibodies.

11. The kit of claim 1 , further comprising a second pair of a capture antibody and a conjugate antibody, wherein said capture antibody and said conjugate antibody in said second pair specifically bind to said second HCV protein or a different HCV protein.

12. The kit of claim 1 , wherein said capture antigen and said capture antibody are attached to a solid phase.

Assignments (6)
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
Reel/Frame 060219/0571 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
SUPPLEMENTAL SECURITY AGREEMENT Recorded Jan 29, 2020
From: ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC
To: BARCLAYS BANK PLC
Reel/Frame 051736/0414 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2018
From: ZHENG, JIAN; YANG, JIANPING
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 045510/0983 →